Ideaya biosciences announces inducement grants under nasdaq listing rule 5635(c)(4)

South san francisco, calif. , nov. 1, 2024 /prnewswire/ -- ideaya biosciences, inc. (nasdaq: idya), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on october 31, 2024, the compensation committee of ideaya's board of directors granted non-qualified stock options to purchase an aggregate of 62,800 shares of the company's common stock to two newly hired employees.
NDAQ Ratings Summary
NDAQ Quant Ranking